David Juurlink

David Juurlink's AcademicInfluence.com Rankings

David Juurlink

Medical

#1402

World Rank

#1738

Historical Rank

Epidemiology

#360

World Rank

#379

Historical Rank

medical Degrees

David Juurlink

Philosophy

#6269

World Rank

#9273

Historical Rank

Logic

#3448

World Rank

#4604

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is David Juurlink Influential?

(Suggest an Edit or Addition)

According to Wikipedia, David Juurlink is a Canadian pharmacologist and internist. He is head of the Clinical Pharmacology and Toxicology division at Sunnybrook Health Sciences Centre in Toronto, Ontario, as well as a medical toxicologist at the Ontario Poison Centre and a scientist at the Institute for Clinical Evaluative Sciences. He is known for researching adverse effects caused by drug interactions, with some of this research funded by a New Investigator Award from the Canadian Institutes for Health Research. He has been very critical of his fellow physicians' regular prescribing of dangerous opioids like Tramadol and fentanyl. In June 2017, he published a letter analyzing citations to "Addiction Rare in Patients Treated with Narcotics", a 1980 letter in The New England Journal of Medicine that has often been cited to claim that opioids like OxyContin are rarely addictive.

(See a Problem?)

David Juurlink's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study (2004) (1001)
Unintended medication discrepancies at the time of hospital admission. (2005) (949)
A population-based study of the drug interaction between proton pump inhibitors and clopidogrel (2009) (767)
Drug-drug interactions among elderly patients hospitalized for drug toxicity. (2003) (728)
Long-term analgesic use after low-risk surgery: a retrospective cohort study. (2012) (653)
Opioid dose and drug-related mortality in patients with nonmalignant pain. (2011) (578)
Medical illness and the risk of suicide in the elderly. (2004) (494)
Guideline for opioid therapy and chronic noncancer pain (2017) (449)
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone (2009) (424)
The Burden of Opioid-Related Mortality in the United States (2018) (423)
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study (2010) (414)
Colchicine poisoning: the dark side of an ancient drug (2010) (413)
Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study (2004) (410)
Risk of incident diabetes among patients treated with statins: population based study (2013) (386)
Outpatient gatifloxacin therapy and dysglycemia in older adults. (2006) (351)
Enhancing the effectiveness of health care for Ontarians through research Canadian Institute for Health Information Discharge Abstract Database : A Validation Study (2006) (349)
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. (2007) (344)
Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case–control study (2017) (322)
Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs (2002) (283)
Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-term risk of acute myocardial infarction in the elderly. (2003) (275)
Hyperbaric oxygen for carbon monoxide poisoning. (2011) (271)
Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. (2011) (270)
Sex-and age-based differences in the delivery and outcomes of critical care (2007) (244)
Risk-treatment mismatch in the pharmacotherapy of heart failure. (2005) (241)
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer. (2012) (216)
Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. (2006) (210)
Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection (2020) (199)
Facing up to the prescription opioid crisis (2011) (189)
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study (2009) (175)
Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. (2005) (166)
Trends in opioid use and dosing among socio-economically disadvantaged patients (2011) (163)
Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. (2006) (163)
Drug‐Induced Lithium Toxicity in the Elderly: A Population‐Based Study (2004) (162)
Considerations when prescribing trimethoprim–sulfamethoxazole (2011) (159)
Rates of hemorrhage during warfarin therapy for atrial fibrillation (2013) (154)
The risk of suicide with selective serotonin reuptake inhibitors in the elderly. (2006) (154)
A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals. (2010) (146)
Opioid dose and risk of road trauma in Canada: a population-based study. (2013) (145)
Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study. (2015) (142)
The burden of premature opioid-related mortality (2014) (142)
Risk of Suicide Following Deliberate Self-poisoning. (2015) (141)
Treatment for calcium channel blocker poisoning: A systematic review (2014) (137)
Testing multiple statistical hypotheses resulted in spurious associations: a study of astrological signs and health. (2006) (137)
Addressing the Opioid Epidemic. (2015) (135)
A 1980 Letter on the Risk of Opioid Addiction. (2017) (133)
Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study (2015) (127)
Trends in high-dose opioid prescribing in Canada. (2014) (125)
Dependence and Addiction During Chronic Opioid Therapy (2012) (115)
The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis (2012) (114)
Polymorphism of the MDR1/ABCB1 C3435T drug‐transporter and resistance to anticonvulsant drugs: A meta‐analysis (2009) (113)
Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario. (2011) (111)
Cholinesterase Inhibitors and Hospitalization for Bradycardia: A Population-Based Study (2009) (110)
Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. (2010) (110)
Pregabalin and the Risk for Opioid-Related Death: A Nested CaseControl Study (2018) (105)
Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada (2018) (104)
The EXTRIP (EXtracorporeal TReatments In Poisoning) workgroup: Guideline methodology (2012) (101)
Chlorthalidone Versus Hydrochlorothiazide for the Treatment of Hypertension in Older Adults (2013) (101)
Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study (2004) (99)
Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults (2017) (97)
Extracorporeal Treatment for Salicylate Poisoning: Systematic Review and Recommendations From the EXTRIP Workgroup. (2015) (97)
Drug interactions with warfarin: what clinicians need to know (2007) (96)
Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study (2016) (91)
Activated charcoal for acute overdose: a reappraisal. (2016) (90)
International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering. (2018) (86)
Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study (2014) (84)
Outcomes of Daytime Procedures Performed by Attending Surgeons after Night Work. (2015) (82)
Statin Toxicity From Macrolide Antibiotic Coprescription (2013) (80)
The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers (2011) (77)
Persistence with therapy among patients treated with warfarin for atrial fibrillation. (2012) (77)
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. (2016) (76)
New Fibrate Use and Acute Renal Outcomes in Elderly Adults (2012) (76)
Geographical variation in opioid prescribing and opioid-related mortality in Ontario. (2011) (75)
Drugs and the QT interval - caveat doctor. (2004) (75)
The prescription opioid epidemic: an overview for anesthesiologists (2015) (75)
Predictors of Opioid-Related Death During Methadone Therapy. (2015) (71)
Extracorporeal treatment for acetaminophen poisoning: Recommendations from the EXTRIP workgroup (2014) (71)
Antipsychotic drugs and hyperglycemia in older patients with diabetes. (2009) (71)
Responding to the opioid crisis in North America and beyond: recommendations of the Stanford–Lancet Commission (2022) (69)
A risk quantification instrument for acute acetaminophen overdose patients treated with N-acetylcysteine. (2005) (68)
Impact of legislation and a prescription monitoring program on the prevalence of potentially inappropriate prescriptions for monitored drugs in Ontario: a time series analysis. (2014) (68)
Hemorrhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. (2010) (68)
Isotretinoin use and the risk of inflammatory bowel disease: a population-based cohort study. (2013) (67)
When do the aminotransferases rise after acute acetaminophen overdose? (2010) (65)
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4 (2015) (65)
Clinical Review: Loperamide Toxicity (2017) (65)
Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study (2014) (65)
Orlistat and acute kidney injury: an analysis of 953 patients. (2011) (64)
Effect of a centralized prescription network on inappropriate prescriptions for opioid analgesics and benzodiazepines (2012) (64)
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study (2011) (63)
Overdose Risk in Young Children of Women Prescribed Opioids (2017) (63)
The Risk of Postpartum Hemorrhage With Selective Serotonin Reuptake Inhibitors and Other Antidepressants (2008) (61)
Oral bisphosphonate use in the elderly is not associated with acute kidney injury. (2012) (59)
Long-term outcomes following self-poisoning in adolescents: a population-based cohort study. (2015) (58)
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903] (2003) (57)
Hyperbaric Oxygen for Carbon Monoxide Poisoning (2005) (57)
Identifying individuals with a reduced GFR using ambulatory laboratory database surveillance. (2005) (57)
Statins and intracerebral hemorrhage: a retrospective cohort study. (2012) (57)
Impact of pharmacist administration of influenza vaccines on uptake in Canada (2017) (56)
Prevention of Opioid Overdose. (2019) (56)
Proton pump inhibitors and clopidogrel: putting the interaction in perspective. (2009) (56)
Trimethoprim–sulfamethoxazole and risk of sudden death among patients taking spironolactone (2015) (55)
Appropriateness of spironolactone prescribing in heart failure patients: a population-based study. (2006) (53)
Antidepressants, Warfarin, and the Risk of Hemorrhage (2005) (52)
Are Broad-Spectrum Fluoroquinolones More Likely To Cause Clostridium difficile-Associated Disease? (2006) (52)
Clinical indications associated with opioid initiation for pain management in Ontario, Canada: a population-based cohort study (2018) (52)
Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval Prolongation in Newborns (2008) (51)
Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis. (2017) (51)
Missed opportunities in the secondary prevention of myocardial infarction: an assessment of the effects of statin underprescribing on mortality. (2006) (50)
Association of Chronic Opioid Use With Presidential Voting Patterns in US Counties in 2016 (2018) (48)
The effect of antidepressant warnings on prescribing trends in Ontario, Canada. (2007) (47)
Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study (2012) (47)
Latest trends in opioid-related deaths in Ontario (2017) (47)
High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study (2016) (46)
Macrolide‐Induced Digoxin Toxicity: A Population‐Based Study (2009) (45)
Multiplying the serum aminotransferase by the acetaminophen concentration to predict toxicity following overdose (2010) (45)
Recurrence and mortality following severe cutaneous adverse reactions. (2014) (45)
Statins and the Risk of Herpes Zoster: A Population-Based Cohort Study (2013) (44)
Availability of antidotes at acute care hospitals in Ontario. (2001) (43)
Dextromethorphan abuse (2014) (43)
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada (2011) (43)
Measuring the Burden of Opioid-related Mortality in Ontario, Canada (2018) (42)
Carfentanil: a narrative review of its pharmacology and public health concerns (2019) (42)
Blood glucose test strips: options to reduce usage (2010) (42)
Extracorporeal treatment for thallium poisoning: recommendations from the EXTRIP Workgroup. (2012) (41)
Heart failure/transplant: abstractsCyclo-oxy genase-2 inhibitors versus nonselective, nonsteroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study☆ (2004) (39)
Neonatal opioid withdrawal and antenatal opioid prescribing. (2015) (39)
Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline (2021) (39)
Safety of influenza vaccination in patients with myasthenia gravis: A population‐based study (2009) (38)
Opioid prescribing is a surrogate for inadequate pain management resources. (2016) (38)
Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada (2015) (38)
Improving opioid prescribing: the New York City recommendations. (2013) (37)
Bupropion abuse and overdose (2014) (36)
Risk of serious falls associated with oxybutynin and tolterodine: a population based study. (2011) (35)
Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study (2012) (35)
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis (2014) (35)
Antipsychotic drugs and the risk of hyperglycemia in older adults without diabetes: a population-based observational study. (2011) (35)
Ciprofloxacin-induced theophylline toxicity: a population-based study (2011) (35)
Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis (2011) (34)
Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation (2017) (34)
Socioeconomic status and risk of hemorrhage during warfarin therapy for atrial fibrillation: A population-based study. (2015) (32)
Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study. (2010) (32)
Proton Pump Inhibitors and the Risk of Adverse Cardiac Events (2013) (32)
Hypokalemia Following Polyethylene Glycol–Based Bowel Preparation for Colonoscopy in Older Hospitalized Patients with Significant Comorbidities (2010) (32)
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study. (2011) (32)
Comparative adherence to oxybutynin or tolterodine among older patients (2012) (30)
Behind the prescriptions: a snapshot of opioid use across all Ontarians (2017) (30)
Clinical consequences of generic warfarin substitution: an ecological study. (2006) (30)
A New Predictor of Toxicity Following Acetaminophen Overdose Based on Pretreatment Exposure (2005) (29)
The Safety of Proton Pump Inhibitors and Clopidogrel in Patients After Stroke (2011) (29)
Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain (2016) (29)
Recurrent Ibuprofen-Induced Aseptic Meningitis (2004) (29)
Adverse cardiac events in older patients receiving venlafaxine: a population-based study. (2014) (28)
Treating acetaminophen overdose: thresholds, costs and uncertainties (2013) (28)
Repetition of intentional drug overdose: a population-based study (2016) (27)
Newly approved does not always mean new and improved. (2008) (27)
Use of other opioids during methadone therapy: a population-based study. (2012) (27)
The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation (2016) (26)
The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men (2014) (26)
Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada. (2012) (26)
Antidote removal during haemodialysis for massive acetaminophen overdose (2013) (26)
Bleeding associated with coadministration of rivaroxaban and clarithromycin (2016) (26)
Medication errors: the human factor (2008) (25)
Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study. (2008) (25)
Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high‐risk population (2012) (25)
New use of rosiglitazone decreased following publication of a meta‐analysis suggesting harm (2008) (25)
Trends of intentional drug overdose among youth: a population-based cohort study (2019) (24)
Use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and cardiovascular outcomes in chronic dialysis patients: a population-based cohort study. (2012) (24)
“Bath salts” (2012) (24)
Hospitalization for hemorrhage among warfarin recipients prescribed amiodarone. (2013) (24)
Trimethoprim/sulfamethoxazole-induced phenytoin toxicity in the elderly: a population-based study. (2011) (24)
Antiepileptic use for epilepsy and nonepilepsy disorders (2016) (23)
Revisiting the drug interaction between tamoxifen and SSRI antidepressants (2016) (23)
Rethinking “doing well” on chronic opioid therapy (2017) (23)
Impact of Unrestricted Access to Pregabalin on the Use of Opioids and Other CNS-Active Medications: A Cross-Sectional Time Series Analysis (2017) (23)
Rosiglitazone and the case for safety over certainty. (2010) (23)
N‐Acetylcysteine for the Treatment of Clove Oil Induced Fulminant Hepatic Failure: Case Report and Review of the Literature (2004) (23)
Depression in chronic pain: might opioids be responsible? (2018) (23)
Inequitable distribution of implantable cardioverter defibrillators in Ontario (2007) (23)
Effect of a course-based intervention and effect of medical regulation on physicians' opioid prescribing. (2013) (23)
Opioid Use and Overdose: What We've Learned in Ontario. (2016) (23)
Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population (2016) (23)
Hyperbaric Oxygen for Carbon Monoxide Poisoning (2000) (23)
Availability of naloxone in Canadian pharmacies:a population-based survey. (2017) (22)
Vasectomy and risk of prostate cancer: population based matched cohort study (2016) (22)
Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study. (2007) (22)
PERSISTENCE WITH BISPHOSPHONATE THERAPY IN OLDER PEOPLE (2006) (22)
Medication use and survival in diabetic patients with kidney cancer: A population-based cohort study. (2016) (22)
Gastrointestinal Decontamination for Enteric-Coated Aspirin Overdose: What to Do Depends on Who You Ask (2000) (22)
A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin. (2005) (22)
Gastrointestinal Decontamination for Enteric-Coated Aspirin Overdose: What to Do Depends on Who You Ask (2000) (22)
Comparing two types of macrolide antibiotics for the purpose of assessing population-based drug interactions (2013) (22)
The Implausibility of Neonatal Opioid Toxicity from Breastfeeding (2020) (21)
PSYCHOTROPIC MEDICATIONS AND MOTOR VEHICLE COLLISIONS IN PATIENTS WITH DEMENTIA (2008) (20)
Iron poisoning in young children: association with the birth of a sibling. (2003) (20)
Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study. (2016) (20)
Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis (2017) (20)
2014 Annual Meeting of the North American Congress of Clinical Toxicology (NACCT) (2014) (20)
Unused prescription drugs should not be treated like leftovers (2014) (19)
Pseudoephedrine-induced toxic epidermal necrolysis. (2005) (19)
Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. (2004) (19)
Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study. (2018) (19)
New Opioid Use After Invasive Mechanical Ventilation and Hospital Discharge. (2020) (18)
Tramadol and hypoglycemia: one more thing to worry about. (2015) (18)
Predictive factors for sleep apnoea in patients on opioids for chronic pain (2019) (18)
A Population‐Based Assessment of the Drug Interaction Between Levothyroxine and Warfarin (2012) (18)
A rare presentation of an ancient disease: scurvy presenting as orthostatic hypotension (2014) (17)
Trends in selection and timing of first‐line pharmacotherapy in older patients with Type 2 diabetes diagnosed between 1994 and 2006 (2013) (17)
Discoloration of skin and urine after treatment with hydroxocobalamin for cyanide poisoning (2009) (17)
Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study (2013) (17)
Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide (2019) (17)
Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: a case-control study. (2012) (17)
The Ontario Drug Policy Research Network: bridging the gap between Research and Drug Policy. (2014) (17)
No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers. (2013) (17)
The enigma of metformin-associated lactic acidosis (2014) (16)
Real-world health care utilization and effectiveness of omalizumab for the treatment of severe asthma. (2018) (16)
Prescription Stimulant Use and Hospitalization for Psychosis or Mania (2015) (16)
The cardiovascular safety of azithromycin (2014) (15)
Corticosteroid‐induced hyperglycemia is increased 10‐fold in patients with pemphigus (2012) (14)
Risk of heart failure and edema associated with the use of pregabalin: a systematic review (2013) (14)
One-Year Mortality After Emergency Department Visit for Nonfatal Opioid Poisoning: A Population-Based Analysis. (2019) (14)
Antidepressants, metoprolol and the risk of bradycardia (2012) (14)
Statin use and kidney cancer outcomes: A propensity score analysis. (2016) (14)
Response to “Association between statin use and ischemic stroke or major hemorrhage in patients taking dabigatran for atrial fibrillation” (2017) (14)
Hospital admissions for hyperkalemia with trimethoprim-sulfamethoxazole: a cohort study using health care database codes for 393,039 older women with urinary tract infections. (2011) (14)
Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada. (2017) (14)
Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study (2017) (14)
A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors (2015) (13)
The Cardiovascular Safety of Dutasteride (2017) (13)
Understanding the Implications of a Shifting Opioid Landscape in Ontario. (2019) (13)
Argyria caused by chronic ingestion of silver (2018) (13)
Drug-induced hepatotoxicity. (2003) (12)
Pregabalin and heart failure: A population‐based study (2017) (12)
Dihydropyridine calcium channel blockers and cardiovascular outcomes in elderly patients: a population-based study. (2008) (12)
Using fractional polynomials to model the effect of cumulative duration of exposure on outcomes: applications to cohort and nested case-control designs (2014) (12)
Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study (2017) (12)
Reformulation of controlled-release oxycodone and pharmacy dispensing patterns near the US–Canada border (2012) (12)
Impact of delisting high‐strength opioid formulations from a public drug benefit formulary on opioid utilization in Ontario, Canada (2019) (12)
The rise and fall of the thiazolidinediones: impact of clinical evidence publication and formulary change on the prescription incidence of thiazolidinediones. (2013) (12)
Upper Gastrointestinal Bleeding in Elderly Adults with Dementia Receiving Cholinesterase Inhibitors: A Population‐Based Cohort Study (2014) (12)
2013 Annual Meeting of the North American Congress of Clinical Toxicology (NACCT) (2013) (11)
Tramadol and the risk of seizure: nested case-control study of US patients with employer-sponsored health benefits (2019) (11)
Who gets antidotes? choosing the chosen few. (2016) (11)
Opioid use and related adverse events in Ontario (2016) (11)
Clopidogrel with or without omeprazole in coronary disease. (2011) (11)
Enhanced Elimination of Dabigatran Through Extracorporeal Methods (2015) (11)
Medication use and kidney cancer risk: A population-based study. (2017) (11)
Carbon monoxide poisoning (2014) (11)
Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults (2018) (10)
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report (2020) (10)
Metronidazole-associated Neurologic Events: A Nested-Case Control Study. (2020) (10)
Self-Monitoring of Blood Glucose Levels: Evaluating the Impact of a Policy of Quantity Limits on Test-Strip Use and Costs. (2016) (10)
Analysis of Trends in Insulin Utilization and Spending Across Canada From 2010 to 2015. (2019) (10)
Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents. (2012) (10)
Prescribing Nirmatrelvir/Ritonavir (Paxlovid) for COVID-19 in Advanced Chronic Kidney Disease. (2022) (10)
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis—reply to Pazianas and Abrahamsen (2014) (10)
Does gastric acid suppression increase the risk of community-acquired pneumonia? (2005) (10)
Diabetes and kidney cancer outcomes: a propensity score analysis (2017) (10)
Trends in the use and cost of antipsychotics among older adults from 2007 to 2013: a repeated cross-sectional study. (2016) (9)
Critical appraisal of the application of propensity score methods in the urology literature (2017) (9)
Initial opioid prescription patterns and the risk of ongoing use and adverse outcomes (2020) (9)
Medicinal cannabis: Time to lighten up? (2014) (9)
Synthetic cannabinoids (2014) (9)
Evaluation of the fentanyl patch-for-patch program in Ontario, Canada. (2019) (9)
Rates of Ischemic Stroke During Warfarin Treatment for Atrial Fibrillation (2015) (9)
Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study. (2013) (9)
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study (2017) (8)
Drug-drug interactions: where do we go from here? (2004) (8)
Ticagrelor and bradycardia: a nested case–control study (2015) (8)
Repetitive transcranial magnetic stimulation (TMS) for medication-resistant depression. (2009) (8)
Risk of overdose and death following codeine prescription among immigrants (2014) (8)
Assessment of Stimulant Use and Cardiovascular Event Risks Among Older Adults (2021) (7)
Dental Opioid Prescription Characteristics and the Risk of New, Persistent Use. (2021) (7)
Medication use and kidney cancer survival: A population‐based study (2018) (7)
The appropriateness and persistence of testosterone replacement therapy in Ontario (2017) (7)
Studying Drug Safety in the Real World. (2018) (7)
Professional Pharmacy Services and Patient Complexity: An Observational Study. (2015) (7)
Trends in the coprescription of proton pump inhibitors with clopidogrel: an ecological analysis. (2015) (7)
Association of Mirabegron With the Risk of Arrhythmia in Adult Patients 66 Years or Older-A Population-Based Cohort Study. (2019) (7)
Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study. (2017) (7)
Tramadol (2013) (7)
Metformin Use and Kidney Cancer Survival Outcomes: A Systematic Review and Meta-Analysis (2019) (7)
The authors respond to “Inconsistencies in the 2017 Canadian Guideline for Opioids for Chronic Noncancer Pain” (2017) (7)
Native valve endocarditis due toCorynebacterium striatum (1996) (7)
High-strength opioid formulations: the case for a ministerial recall (2018) (6)
Second-generation anti-depressants and risk of new-onset seizures in the elderly (2018) (6)
Lofexidine for Opioid Withdrawal: Small Effects at an Exorbitant Price. (2018) (6)
How Many “Me-Too” Drugs are Enough? The Case of Physician Preferences for Specific Statins (2006) (6)
The effect of publication on Internet-based solicitation of personal-injury litigants (2007) (6)
Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain. (2012) (6)
Deliberate self-poisoning in Ontario following the terrorist attacks of September 11, 2001. (2005) (6)
Major trauma in elderly adults receiving lipid-lowering medications. (2001) (6)
Rates of Anomalous Bupropion Prescriptions in Ontario, Canada (2015) (6)
The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario (2016) (6)
The impact of federal warnings on publically funded desmopressin utilization among children in Ontario. (2012) (6)
Drug safety in patients with heart failure. (2005) (5)
Loperamide abuse (2017) (5)
Fluoroquinolones and the aorta (2018) (5)
The authors respond to “The 2017 Canadian opioid guideline: already time for an overhaul” (2018) (5)
Guillain-BarreSyndrome After Influenza Vaccination in Adults (2006) (5)
Covariate adjustment in RCTs results in increased power to detect conditional effects compared with the power to detect unadjusted or marginal effects (2010) (5)
The value of complementing administrative data with abstracted information on smoking and obesity: A study in kidney cancer. (2017) (5)
The Prescription Opioid Epidemic: Social Media Responses to the Residents' Perspective Article. (2016) (5)
COX-2 inhibitors and risk of heart failure (2004) (5)
Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy (2022) (5)
Prescribing Nirmatrelvir/Ritonavir for COVID-19 in Advanced CKD (2022) (5)
Individual opioids, and long- versus short-acting opioids, for chronic noncancer pain (2019) (5)
Kappa statistic (2005) (5)
The impact of policies to reduce blood glucose test strip utilization and costs in Canada (2015) (5)
Progression through diabetes therapies among new elderly users of metformin: a population‐based study (2013) (5)
Carbon monoxide treatment guidelines must acknowledge the limitations of the existing evidence. (2013) (5)
Opioid related deaths in Ontario between 1991 and 2010 (2014) (5)
Circumcision and Risk of HIV among Males from Ontario, Canada (2021) (5)
Impact of the JUPITER Trial on Statin Prescribing for Primary Prevention (2014) (5)
Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program. (2018) (5)
Sevelamer prescriptions after reporting of the Dialysis Clinical Outcomes Revisited (DCOR) trial findings: An analysis of 5,495 patients receiving maintenance dialysis in Ontario, Canada. (2011) (5)
Etravirine(Intelence) for HIV infection. (2008) (4)
Antidepressants, antiplatelets and bleeding: One more thing to worry about? (2011) (4)
Discrepant advice from poison centres and their medical directors. (2002) (4)
Comprehensive Drug-Class Review Framework for improved evidence-based drug policy and formulary modernization (2019) (4)
Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use (2021) (4)
Assessing the impact of an opioid prescribing guideline for dentists in Ontario, Canada. (2019) (4)
Drug interactions with simvastatin. (2008) (4)
A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride (2018) (4)
Pharmacogenetic-Based Dosing of Warfarin (2008) (4)
Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population‐based time–series analysis (2020) (4)
Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis. (2017) (4)
A Granisetron Patch (Sancuso) (2008) (4)
Methylnaltrexone (Relistor) for opioid-induced constipation (2008) (4)
Response to “Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids” (2017) (4)
Clopidogrel and proton pump inhibitors (2014) (4)
ST-elevation in ethylene glycol toxicity mimicking myocardial infarction. (2019) (3)
Painful decision-making at FDA (2014) (3)
Lipophilic &bgr;-Blockers and Suicide in the Elderly (2017) (3)
ICES Report: Avoiding Drug Interactions in Hospitalized Patients (2004) (3)
Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised trials. (2022) (3)
Prescribing of opioids and opioid-related mortality in Ontario: 2004 - 2006 (2012) (3)
Lacosamide for epilepsy. (2009) (3)
Extended-release nifedipine and the risk of intestinal obstruction: a population-based study (2014) (3)
Impact of changes in opioid funding and clinical policies on rapid tapering of opioids in Ontario, Canada (2021) (3)
Opioid Overuse or NSAID Underuse? A Response to the Pain Guide. (2017) (3)
Critiquing the CDC Opioid Guideline: Some Light From the Heat (2018) (3)
Maternal infection can cause spontaneous abortion (2017) (3)
Does the treatment of dyslipidemia affect the risk of depression or suicidal behaviour? (2004) (3)
Melatonin (2012) (3)
Opioid use in pregnancy: An emerging health crisis (2020) (3)
Comment: Clarithromycin-Digoxin Interaction (1999) (3)
Avoiding drug interactions in hospitalized patients. (2004) (2)
The Risk of Ventricular Dysrhythmia or Sudden Death in Patients Receiving Serotonin Reuptake Inhibitors With Methadone: A Population-Based Study (2022) (2)
Maternal opioid treatment after delivery and risk of adverse infant outcomes: population based cohort study (2023) (2)
Linking the Narcotics Monitoring System Database to Quantify the Contribution of Prescribed and Non-Prescribed Opioids to Opioid Overdoses in Ontario, Canada (2018) (2)
Comparative adherence to oxybutynin or tolterodine among older patients (2012) (2)
Cost Minimal Effectiveness of SMBG (2010) (2)
Fetal exposure to ACE inhibitors increased risk of major congenital malformations (2007) (2)
Opioid prescribing and opioid-related hospital visits in Ontario (2016) (2)
Adherence to prescribing recommendations made on a provincial formulary. (2014) (2)
Ketamine for the treatment of acute pain (2021) (2)
A case of recurrent meningitis (2006) (2)
Tetrabenazine (Xenazine) for Huntington's chorea. (2009) (2)
Metronidazole-induced neurotoxicity (2021) (2)
Trends in Postpartum Opioid Prescribing: A Time Series Analysis (2021) (2)
Sunscreens: An update (2008) (2)
Oxycodone, Hydromorphone, and the Risk of Suicide: A Retrospective Population-Based Case–Control Study (2020) (2)
Off-label use of inhaled tobramycin in Ontario, Canada (2016) (2)
Review: nonselective nonsteroidal antiinflammatory drugs do not increase risk for cardiovascular events. (2007) (2)
Prevention of venous thromboembolism in orthopedic surgery. (2008) (2)
COX-2 inhibitors and risk of heart failure. Authors' reply (2004) (2)
Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study (2015) (2)
Clinical and demographic characteristics of patients receiving different oral hypoglycemic agents (2009) (2)
Recurrence of Stevens-Johnson syndrome and toxic epidermal necrolysis--reply. (2014) (2)
New Opioid Use and Risk of Emergency Department Visits Related to Motor Vehicle Collisions in Ontario, Canada (2021) (2)
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study. (2021) (2)
Sapropterin (Kuvan) for phenylketonuria. (2008) (2)
Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study (2021) (2)
Loperamide Cardiac Toxicity - Pathophysiology, Presentation and Management. (2022) (2)
Recombinant human antithrombin (ATryn). (2009) (2)
Antiepileptic drugs and warfarin (2008) (2)
Baseline comparisons in randomized controlled trials (2010) (2)
Tocilizumab (Actemra) for giant cell arteritis. (2017) (2)
Better Studies Are Needed to Guide Treatment of Carbon Monoxide Poisoning. (2017) (2)
Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada. (2017) (2)
ACMT Position Statement: Caring for Patients with Opioid Use Disorder during Coronavirus Disease Pandemic (2020) (2)
Multidose activated charcoal for yellow oleander poisoning (2003) (2)
The headache of teenage acne (2004) (2)
Celecoxib increased cardiovascular events in patients with colorectal adenomas. (2005) (2)
Patterns of antidepressant use among women initiating tamoxifen therapy for the treatment of breast cancer in Ontario, Canada. (2010) (2)
Challenges Interpreting Chemoprevention Studies Using Observational Data. (2017) (2)
Bimatoprost 0.03% solution (latisse) for eyelash enhancement. (2009) (2)
Do Ontario patients with heart failure have equal access to life-saving technology? (2008) (2)
Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants (2017) (2)
Bendamustine (Treanda) for CLL and NHL. (2008) (1)
Valproic acid delayed release (Stavzor). (2009) (1)
ECGs before stimulants in children. (2008) (1)
Association between type of opioid prescribed postpartum and persistent opioid use: a population-based cohort study (2021) (1)
What the Internet can and cannot tell us about emerging toxicologic outbreaks (2012) (1)
Opioids and Dose-Related Deaths—Association or Causation?—Reply (2011) (1)
Do statins decrease the risk of colorectal cancer? (2005) (1)
Are selective COX 2 inhibitors superior to traditional NSAIDs? Little is known about COX 2 inhibitors. (2002) (1)
The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis (2021) (1)
Authors’ reply to Scheper and Lijfering (2014) (1)
Changing patterns of opioid initiation for pain management in Ontario, Canada: A population-based cross-sectional study (2022) (1)
Antidepressant use, serotonin transporter affinity, and reinfarction among patients receiving clopidogrel: a population‐based study (2012) (1)
Opioid Initiation and the Hazard of Falls or Fractures Among Older Adults with Varying Levels of Central Nervous System Depressant Burden (2022) (1)
Reply to Strandberg and Tienari. (2014) (1)
Screening for oral cancer (2009) (1)
Varenicline and Risk of Self-Harm: A Nested Case-Control Study (2016) (1)
Hyperbaric oxygen for carbon monoxide poisoning. (2005) (1)
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment (2021) (1)
Dronedarone (Multaq) for atrial fibrillation. (2009) (1)
Hyperkalemia and Inhibitors of the Renin-Angiotensin- Aldosterone System (2004) (1)
The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study (2022) (1)
Advice for Physicians in Training: 40 Tips From 40 Docs (2014) (1)
Intravenous Ibuprofen (Caldolor) (2010) (1)
Drug-Induced Hepatotoxicity [5] (multiple letters) (2003) (1)
Circumcision and Risk of HIV Among Males from Ontario, Canada. Reply. (2021) (1)
Zingo for local analgesia in children. (2008) (1)
The safety of over-the-counter niacin: a randomised, placebo-controlled blinded trial (2010) (1)
Drugs for cognitive loss and dementia. (2017) (1)
Impact of a Graduated Approach on Opioid Initiation and Loss of Earnings Following Workplace Injury (2017) (1)
New findings highlight potential risks of common drug combination in cardiac patients. (2009) (1)
Silodosin (Rapaflo) for benign prostatic hyperplasia. (2009) (1)
Red yeast rice (2009) (1)
Self-monitoring of blood glucose: Patterns, Costs and Potential Cost Reduction Associated with Reduced Testing (2009) (1)
Debating the opioid guidelines: context. (2018) (1)
Lymphocytic colitis associated with entacapone (2022) (1)
Olapatadine (Patanase) nasal spray for allergic rhinitis. (2008) (0)
Enhanced Elimination of Dabigatran Through Extracorporeal Methods (2014) (0)
Addressing inaccurate claims about the Canadian opioid guideline. (2019) (0)
678 Ace inhibitor and angiotensin receptor blocker use and cardiovascular outcomes in dialysis patients: A population-based cohort study in Ontario, Canada (2011) (0)
Patients treated with aspirin after a first myocardial infarction who also receive a proton pump inhibitor have a higher incidence of cardiovascular events (2011) (0)
Abstract 6: Inequitable Distribution of Implantable Cardioverter-Defibrillators in Ontario, Canada (2006) (0)
Prolongation in Newborns Antenatal Use of Selective Serotonin-Reuptake Inhibitors and QT Interval (2008) (0)
Dutasteride (Avodart) with tamsulosin (Flomax) for benign prostatic hyperplasia. (2008) (0)
Intubation and salicylate overdose. (2017) (0)
What's in November's studentBMJ? (2005) (0)
934: The effects of interventions for calcium channel blocker (CCB) poisoning (2013) (0)
Comparative adherence to oxybutynin or tolterodine among older patients (2011) (0)
Extracorporeal treatment in salicylate poisoning (2018) (0)
Combining activated charcoal with whole-bowel irrigation. Authors' reply (2002) (0)
MP64-18 CHEMOPREVENTION IN KIDNEY CANCER: SURVIVAL OUTCOMES IN DIABETICS (2016) (0)
Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study (2023) (0)
Letter-in-reply. (2020) (0)
Debating the opioid guidelines: corrections. (2018) (0)
A search strategy to identify published reports of randomized controlled trials in PubMed (2010) (0)
Abstracts from the 33rd Annual Scientific Meeting of the Canadian Geriatrics Society Toronto, April 2013 (2013) (0)
PD31-12 MIRABEGRON AND THE RISK OF ARRHYTHMIAS: A POPULATION-BASED COHORT STUDY (2019) (0)
PIII-77Repetition of deliberate self-poisoning: A longitudinal population-based study (2006) (0)
When a statin fails. (2009) (0)
Home Current Issue All Issues Online First Collections In the Clinic Journal Club CME (2013) (0)
Risk of SARS-CoV-2 infection following initial COVID-19 vaccination: Population-based cohort study (2022) (0)
Association Between PPI Exposure and Readmission for Stroke Among Patients Receiving Clopidogrel After Stroke (2010) (0)
Another once-daily formulation of tramadol (Ryzolt). (2010) (0)
In Memoriam Michael Alister McGuigan, M.D. (2019) (0)
Hyperbaric oxygen should not be used routinely for carbon monoxide poisoning (2022) (0)
Response to “understanding the behavioural determinants of opioid prescribing among family physicians: a qualitative study” (2020) (0)
Characteristics of Opioid-Related Deaths in Ontario, Canada: Leveraging the Drug and Drug/Alcohol Related Death (DDARD) Database (2018) (0)
Response to “Opioids for chronic pain” (2019) (0)
Performance of the disease risk score in a cohort study with policy-induced selection bias. (2015) (0)
Risk of Death Due to Breast Cancer in Women Treated with Selective Serotonin Reuptake Inhibitor Antidepressants and Tamoxifen. (2009) (0)
Latest trends in opioid-related deaths: exploring differences among men and women (2017) (0)
Rofecoxib increased thrombotic events in patients with colorectal adenomas. (2005) (0)
Artemether-lumefantrine (Coartem) for treatment of malaria. (2009) (0)
A159 OPIOID USE IS DECLINING AMONG PEOPLE WITH INFLAMMATORY BOWEL DISEASE: A POPULATION-BASED STUDY (2022) (0)
Adapalene-Benzoyl Peroxide (Epiduo) for Acne (2009) (0)
The EarCheck Middle Ear Monitor for detection of middle ear effusion in children. (2008) (0)
Mercury, Coronary Heart Disease, and the Limits of Observational Epidemiology (2004) (0)
Comparative adherence to oxybutynin or tolterodine among older patients (2012) (0)
Correction to: Carfentanil: a narrative review of its pharmacology and public health concerns (2019) (0)
Heat and transdermal fentanyl (2009) (0)
Making Evidence Matter in Canadian Health Policy (2014) (0)
Publicly Funded Oral Chronic Hepatitis B Treatment Patterns in Ontario over 16 Years: An Ecologic Study. (2018) (0)
Introduction to a series of Pro/Con papers in Clinical Toxicology (2021) (0)
anesthesiologists L'epidemie de prescription d'opioõ ¨des: une vue d'ensemble destinee aux anesthesiologistes (2016) (0)
In Memoriam Michael Alister McGuigan, M.D. (2019) (0)
Rufinamide (Banzel) for epilepsy. (2009) (0)
Correction: High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study (2017) (0)
Which is More Injurious: Cannabis or Alcohol? (2015) (0)
PII‐77 (2006) (0)
Coming Soon in The Medical Letter: Lisdexamfetamine dimesylate (Vyvanse) for ADHD Lybrel — A New Contraceptive Pill Lapatinib (Tykerb) for Breast Cancer (2007) (0)
Multiplying the Serum Acetaminophen by the Aminotransferase to Risk-stratify Patients Following Acetaminophen Overdose (2007) (0)
Treating acetaminophen overdose (2022) (0)
Impact of a Publicly-Funded Pharmacare Program on Prescription Stimulant use Among Children and Youth: A Population-Based Observational Natural Experiment. (2023) (0)
Insulin glargine (Lantus) and cancer risk. (2009) (0)
SAFETY OF INFLUENZA VACCINATION: RISK―BENEFIT EVALUATION. Authors' reply (2010) (0)
Comment on Shively et al. “Acute salicylate poisoning: risk factors for severe outcome” (2017) (0)
Dr. Juurlink Replies (2006) (0)
Drugs for MRSA with reduced susceptibility to vancomycin. (2009) (0)
Low-voltage electronic diagnostic devices. (2008) (0)
Variations in costs and use of provincially-funded testosterone replacement therapy across Canada: a population-based study (2016) (0)
Clinical Research Novel Oral Anticoagulants and the Risk of Major Hemorrhage in Elderly Patients With Chronic Kidney Disease: A Nested Case-Control Study (2016) (0)
Family Medicine Forum Research Proceedings 2015 Toronto, Ont (2016) (0)
Antipsychotic and sedative use in long-term care (LTC) homes in Ontario (2014) (0)
Upper GI bleeding with NSAIDS and warfarin (2005) (0)
Combining activated charcoal with whole-bowel irrigation. (2002) (0)
Antiemetics, stroke, and the limits of observational epidemiology (2022) (0)
New opioid use and risk of opioid-related adverse events among adults with intellectual and developmental disabilities in Ontario, Canada (2022) (0)
Issue highlights. (2016) (0)
Abstract 2118: A Population-based Comparison of the Cardiovascular Protective Effects of Hydrochlorothiazide and Chlorthalidone (2007) (0)
Navigating the Evidence: Communicating Canadian Health Policy in the Media (2015) (0)
REVIEW-THEMED ISSUE Who gets antidotes? choosing the chosen few (2016) (0)
A162 CHRONIC OPIOID THERAPY IS ASSOCIATED WITH INCREASED HEALTH SERVICES UTILIZATION AND DIRECT HEALTHCARE COSTS: A POPULATION-BASED STUDY (2022) (0)
M1969 The Treatment of Esophageal Adenocarcinoma in Usual Practice: A Population-Based Study (2009) (0)
Golimumab (simponi) for inflammatory arthritis. (2009) (0)
First-line therapy in drug reaction with eosinophilia and systemic symptoms (DReSS): Thinking beyond corticosteroids (2023) (0)
Dissociative Disorder Underdiagnosed Due to Undescriptive Criteria (2006) (0)
Rofecoxib for colorectal adenomas increased thrombotic events (2005) (0)
Dependence and Addiction During Chronic Opioid Therapy (2012) (0)
Withholding 4-methylpyrazole pretreatment in suspected toxic alcohol ingestions. (2005) (0)
Ciclesonide (Alvesco)-a new inhaled corticosteroid for asthma. (2008) (0)
Pneumococcal vaccination of adults: polysaccharide or conjugate. (2009) (0)
Interaction between clopidogrel and proton pump inhibitors (2009) (0)
MEDICATION USE AND KIDNEY CANCER RISK: A POPULATION‐BASED STUDY: PD52‐07 (2017) (0)
Response to “Winner of the Ronald Melzack — Canadian Journal of Pain 2021 Paper of the Year Award” (2022) (0)
REVIEWARTICLE Dependence and Addiction During Chronic Opioid Therapy (2012) (0)
Celecoxib for colorectal adenomas increased CV events (2005) (0)

This paper list is powered by the following services:

Other Resources About David Juurlink

en.wikipedia.org

What Schools Are Affiliated With David Juurlink?

David Juurlink is affiliated with the following schools:

University of Toronto

David Juurlink's Academic­Influence.com Rankings

Why Is David Juurlink Influential?

David Juurlink's Published Works

Published Works

Other Resources About David Juurlink

What Schools Are Affiliated With David Juurlink?

David Juurlink's AcademicInfluence.com Rankings